Human immunodeficiency virus type 1 Gag, Pol, and Nef epitopes (HIV-1 Gag, Pol, Nef)

Human immunodeficiency virus type 1 (HIV-1) encodes several essential and accessory proteins, including Gag (group-specific antigen), Pol (polymerase), and Nef (negative regulatory factor). Gag is a structural polyprotein critical for virion assembly, membrane targeting, and budding[2][6][7]. Pol, translated as part of the Gag-Pol precursor, contains viral enzymes necessary for replication such as protease, reverse transcriptase, and integrase[7]. Nef is an accessory protein that optimizes viral replication and immune evasion by modulating host cell signaling, trafficking, and surface expression of cellular proteins[3][4][5]. While the proteins themselves are not “receptors,” their *epitopes*—short immunogenic peptide sequences—are key targets for the cellular immune response and vaccine development, not for classical small-molecule drug discovery. Drugs in current HIV therapy specifically target the Pol polyprotein enzymes but not Gag or Nef directly. The therapeutic significance of Gag, Pol, and Nef epitopes lies primarily in their use as antigens to study host immune responses or in vaccine research, rather than as discrete molecular drug targets. The name "HIV-1 Gag, Pol, Nef epitopes" is therefore not a true canonical target.

Other names

HIV-1 Gag proteinHIV-1 Pol proteinHIV-1 Nef proteinHIV-1 group-specific antigenHIV-1 polymeraseHIV-1 negative regulatory factor

Inhibition of protease (preventing virion maturation) Inhibition of reverse transcriptase (blocking viral DNA synthesis) Inhibition of integrase (blocking viral DNA integration) Approaches targeting Nef (experimental; aim to restore immune recognition and block host protein trafficking)